ENZ: Enzo Biochem, Inc. Company Profile & Statistics

About

Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.

Info & Links

CEO

Kara Cannon

Headquarters

21 Executive Blvd.
FARMINGDALE, NY 11735, UNITED STATES

Auditor

EisnerAmper LLP

Share holders

685

Employees

136

Enzo Biochem, Inc. Statistics

Valuation Measures

Market Capitalization²

36.83M

Enterprise Value

-15.35M

Enterprise Value/EBITDA(ttm)

1.38

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

1.67

Price to Book(mrq)

0.94

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

45.74%

Operating Margin(ttm)

-25.05%

Profit Margin(ttm)

-84.00%

Return on Equity(ttm)

-11.84%

Return on Invested Capital(ttm)

-13.95%

Return on Assets(ttm)

-8.31%

Income Statement

Revenue(ttm)

31.91M

Revenue Per Share(ttm)

0.61

Gross Profit(ttm)

14.63M

EBITDA(ttm)³

-11.09M

Net Income Available to Common(ttm)

-26.08M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

0.75

52-Week Change

-38.67%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

52.24M

Dividend Yield

39.22%

Float⁴

46.29M

% Held by Insiders

11.40%

% Held by Institutions

36.90%

Balance Sheet

Total Cash(mrq)

52.37M

Total Cash Per Share(mrq)

1.00

Total Debt(mrq)

189.00K

Total Debt/Equity(mrq)

0.34%

Current Ratio(mrq)

2.82%

Quick Ratio(mrq)

2.55%

Book Value Per Share(mrq)

1.07

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.52

Free Cash Flow(ytd)

-26.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ENZ

Enzo Biochem, Inc.

Enzo Biochem, Inc. Profile